Acute-onset bronchial asthma causes wheezing and breathlessness as a result of which of these processes?

Choice A rationale

Acute-onset bronchial asthma is fundamentally characterized by airway inflammation, which involves the infiltration of inflammatory cells, such as mast cells and eosinophils, leading to the release of mediators like histamine and leukotrienes. This triggers bronchoconstriction (smooth muscle spasm), mucosal edema, and mucus production, collectively reducing the airway diameter and airflow, which clinically manifests as wheezing and breathlessness.

Choice B rationale

Alveolar collapse, or microatelectasis, is a consequence of hypoxemia or reduced surfactant, not the primary cause of acute asthmatic symptoms. Acute asthma mainly affects the bronchi and bronchioles by causing inflammation and bronchospasm, which hinders airflow. Alveolar function is compromised secondarily by impaired ventilation, but the obstructive process in the airways is the main source of wheezing.

Choice C rationale

Compression atelectasis is typically caused by external pressure on the lung tissue, such as a pleural effusion or a large tumor, leading to the collapse of the underlying alveoli. This is not the primary pathophysiologic mechanism in acute bronchial asthma, which is characterized by intrinsic airway obstruction due to inflammation, edema, and bronchospasm within the bronchial walls.

Choice D rationale

Pulmonary hypertension, characterized by elevated blood pressure in the pulmonary arteries (normal range: systolic 15-30 mmHg), can be a long-term complication of severe, chronic respiratory disease, but it is not the acute-onset process directly responsible for the immediate wheezing and breathlessness in asthma. The acute symptoms are due to airway narrowing from bronchospasm and inflammation.

Choice A rationale

Absorption is the movement of a drug from its site of administration into the bloodstream. While infection or inflammation can alter local blood flow and affect absorption for some routes (e.g., subcutaneous), the primary issue with an abscess is the limited delivery of the drug from the central circulation to the localized, avascular lesion.

Choice B rationale

Distribution is the reversible movement of a drug from the systemic circulation into the body's tissues. An abscess is an encapsulated collection of pus, typically surrounded by a thick, avascular (lacking blood vessels) wall. This structure significantly impedes the physical distribution of systemically administered antibiotics from the blood into the infected, sequestered area, making the drug less effective.

Choice C rationale

Metabolism (or biotransformation) is the chemical alteration of a drug by the body, mainly in the liver, often rendering it inactive and more easily excreted. The localized abscess barrier affects drug delivery to the target site, not its systemic breakdown. The liver function is generally unimpaired by the localized infection in terms of metabolism.

Choice D rationale

Excretion is the removal of the drug or its metabolites from the body, primarily via the kidneys. While severe infection can cause septic shock and lead to acute kidney injury (AKI), altering excretion, the direct effect of a localized abscess on antibiotic effectiveness is the impaired penetration or distribution into the walled-off infection site.